期刊
CURRENT OPINION IN BIOTECHNOLOGY
卷 24, 期 1, 页码 60-68出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.copbio.2012.11.001
关键词
-
资金
- Fonds National de la Recherche Luxembourg (FNR) ATTRACT [FNR/A10/03]
Cancer is a disease of unregulated cell growth and survival, and tumors reprogram biochemical pathways to aid these processes. New capabilities in the computational and bioanalytical characterization of metabolism have now emerged, facilitating the identification of unique metabolic dependencies that arise in specific cancers. By understanding the metabolic phenotype of cancers as a function of their oncogenic profiles, metabolic engineering may be applied to design synthetically lethal therapies for some tumors. This process begins with accurate measurement of metabolic fluxes. Here we review advanced methods of quantifying pathway activity and highlight specific examples where these approaches have uncovered potential opportunities for therapeutic intervention.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据